Recently, I had the chance to reflect on chairing #ASCO2025, the evolving landscape of breast cancer research, and why patient-centered innovation matters more than ever. #SCRIOncologyPartners 📖 www.emjreviews.com/en-us/amj/on... #Oncology #BreastCancer #ClinicalTrials #Leadership

VERITAC-2 shows vepdegestrant improves PFS after CDK4/6i among pts with HR+ mutESR1 MBc, from 2.1 months to 5.0 months. @erikahamilton9.bsky.social @oncoalert.bsky.social #ASCO25

The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸 @elisaagostinetto.bsky.social‬ @erikahamilton9.bsky.social‬ @drsgraff.bsky.social‬ @elisabettabonzano.bsky.social‬

Another positive trial in #bcsm, TDXd followed by THP beats ddAC-THP in neoadjuvant HER-2+ early breast cancer. We've seen a lot of positive TDXd results, but this is the FIRST 🥇in the early stage setting! @oncbrothers.bsky.social @oncoalert.bsky.social www.astrazeneca.com/media-centre...

Maple was very interested in the Derby 🐎

Molecular Profiling, Endocrine Sensitivity Are Key to Managing Later-Line HR+/HER2-Negative Breast Cancer @erikahamilton9.bsky.social #bcsm #oncology www.onclive.com/view/molecul...

Look at what our practice did for us for Doctor's Day this year? Seriously so cute and thoughtful. Definitely my best Doctor's Day ever! Thank you SCRI Oncology Partners!

#JSMO25 was amazing! 💪🏼 Had a fantastic session led by Makiko Ono on gender balance in oncology, ⭐️ a great joint @ascocancer.bsky.social / JSMO session on undruggable targets, 🌹 a beautiful Presidential Dinner.... 🇯🇵 and got to squeeze in a visit to a shrine!

It's almost like we knew we didn't want measles and all were getting vaccinated so we didn't have to live like it was in 1950 🤷🏼‍♀️ PSA: anti-vax isn't cool, it isn't protecting your family. You and your family don't want complications from diseases that can be prevented.

Happy to have participated in #SERENA6, using ctDNA to tailor an early switch strategy for metastatic HR+ disease. Could make ctDNA actually ACTIONable in breast for the first time! www.astrazeneca.com/media-centre...

Asia Pacific Breast Cancer Symposium

Proud to collaborate with @scrinetwork.bsky.social at Great Debates in Solid Tumors! Join Co-Chairs @erikahamilton9.bsky.social & @drkatymoore.bsky.social, plus Andrew McKenzie PhD, & @viveksubbiah.bsky.social, leading key discussions on solid tumors. 🔗 gdsolidtumors.com #Oncology #CancerResearch

My kid has to select the proper US state as an online interactive map calls them out in random order in under 2 minutes. I can't even come close. It's near impossible when you have to zoom in on small states in the NE to accurately press the right tiiiny state on an iPad and then zoom back out.

TODAY🚨 #OncoAlertColloquium #BreastCancer ✅FREE REGISTRATION👉 buff.ly/4jJy808 ✅ACCESS👉 vimeo.com/event/4875736 ⭐️A PASSWORD IS NEEDED, hence REGISTRATION IS NEEDED @erikahamilton9.bsky.social @hoperugo.bsky.social @drsgraff.bsky.social @maryamlustberg.bsky.social @elisaagostinetto.bsky.social

Soooooo....I guess my addictive habit of buying cheap light-up seasonal decorations from Temu for less than $5 is drying up next week, huh? Have to admit, I've been super pleasantly surprised by this stuff.

OncoAlert🚨Network with our partners at ESSO, ESGO, MASCC & SIOG invite you to the #OncoAlertColloquium NEXT WEEK!! FREE REGISTRATION HERE👉 buff.ly/3CChgre February 3-9, 2025 💯% Virtual & Interactive @erikahamilton9.bsky.social @drsgraff.bsky.social @drjnaidoo.bsky.social @hoperugo.bsky.social

This is huge. The European equivalent to the FDA has said enough to the propaganda machine X. Others will follow. #medsky #oncosky www.reuters.com/world/europe...

DB-06 #TDXD approved for HER-2 "ultra low" (IHC but staining) breast cancer, and 1st line moving this drug up. #bcsm @oncoalert.bsky.social www.astrazeneca.com/media-centre...

The tiny amount of aluminum helps make certain vaccines even more effective& has a strong safety record. “In the first six months of babies’ lives, vaccines expose them to roughly 4.4 milligrams of aluminum. One slice of American cheese, by contrast, can contain as much as 50 milligrams of aluminum”

Anyone need motivation for a flu shot? My middle school daughter's basketball game for today was postponed to next week because the opposing team doesn't have 5 players to dress that don't currently have the flu. 😷

Fantastic thread about why freezing the NIH has far reaching consequences.

Yes, I have to confirm this is completely normal. Been through this stage x 2. In better news, it tends to go away in half a year.

Hot off the press 📰 - we have a 2nd TROP-2 ADC for #bcsm Saci: D#1,8 -💩 low WBC Dato: q3 wks - 👄 sores Nice to have options for our patients @oncoalert www.reuters.com/business/hea...

Who has tried to add Palbo to maintenance let + HP? Know it isn't "approved yet", but wasn't successful. Anyone been successful for coverage yet with #PATINA? @ptarantinomd.bsky.social @hoperugo.bsky.social @stolaney1.bsky.social @vkaklamani.bsky.social @jochien.bsky.social

The OncoAlert🚨 Network along with our partners at ESSO, ESGO, MASCC & SIOG invite you to the #OncoAlertColloquium REGISTER for FREE HERE👉 buff.ly/3CChgre February 3-9, 2025 💯% Virtual & Interactive @erikahamilton9.bsky.social @drsgraff.bsky.social @drjnaidoo.bsky.social @hoperugo.bsky.social

Why does coming in and seeing a new leaf on my office monastera make me irrationally happy? #plants #simplejoys #makeagreatday

Remember iron lungs for polio? No? Me, either. Because vaccines work! @arghavansallesmd.bsky.social @thanhneville.bsky.social @castltrastondrs.bsky.social @cclaremdmph.bsky.social

Hello Mexico City! 🇲🇽

Merry Christmas to all! We are ready here in Nashville- reindeer food has been spread and matching jammies are on. Goodnight to everyone! Hope your holiday is filled with happiness, joy, and a touch of magic!

Some of us sat down with @foxnewscorporation.bsky.social to recap 2024 in cancer Ana make some predictions for the new year of 2025! @viveksubbiah.bsky.social @krishpatelmd.bsky.social www.foxnews.com/health/year-...

Anyone have restaurant recommendations in Mexico City that would be appropriate for kids? Know that Pujol and Bika etc do not allow kids. We already have Animal at St. Regis. When the internet search suggested "Texas Roadhouse Mexico City" as #1, I realized it had no idea what I was going for. 😳😒

Excited to be elected to @ascocancer.bsky.social's Nomination Committee. A great honor to be able to contribute to future leaders in oncology. Thank you for all your support. Can't wait for #ASCO25, remember to submit your abstracts by January 28th. #Oncology #ASCO connection.asco.org

Our elf, Sparkles, is apparently not afraid of heights. #Christmas #TisTheSeason

Need to spread the word on all presentations and push for handles to move from the other place to bluer skies. My last slide @sabcs.bsky.social

Today seems like a good day to share this Scientific American story on how vaccines have saved more lives throughout history than any other intervention

Welcome @ascocancer.bsky.social!

Kudos to Dr Krop for. Great balanced discussion. MRD testing has great promise but also brings great potential for harm. Success of any MRD test is inextricably linked to success of our therapeutic interventions. We’re just not there yet. Bottom line…don’t do it #SABCS2024

Fantastic ER+ #bcsm summary and algorithm by Dr. Danso at year in review. First line CDK 2nd line profile driven ADC/chemo once endo-R! @sabcs.bsky.social #SABCS24 @oncoalert.bsky.social

Y'all...Mike Danso isn't on social media. He said we may be able to convince him to join- give me some likes from #SABCS24!

Did anyone else buy Sally the Armadillo for their kids? Raise 🖐️ Hard to make an armadillo look cute, but they nailed it. #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social

Dr. Bianchini describes the 🐘 in the room at #SABCS24. ❓Are PD-L1 and PD1 not created equal in breast? 🔑It is clear, neoadjuvant compared to adj immunotherapy should be given ⚠️ highlights ER low should be included in ICI trials #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social

Dr. Bianchini describes the 🐘 in the room at #SABCS24. ❓Are PD-L1 and PD1 not created equal in breast? 🔑It is clear, neoadjuvant compared to adj immunotherapy should be given ⚠️ highlights ER low should be included in ICI trials #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social

Anthracyclines still have a role in the treatment of those patients with early breast cancer at very high risk of disease recurrence!

Dr. Chen shows that benefit of anthracycline is really beneficial for those with HIGH recurrence score (5% benefit) Benefit primarily limited to tumors >2cm Benefit in both pre and post meno Alternative regimens not as good as T-AC #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social

Dr. Krop emphasizes we don't have the data in #bcsm that the GI literature does for MRD. 🛑 Should NOT order tests (outside of a clinical trial) without clear actions to take based on results ‼️ ❓Will outcomes be changed in ctDNA+? Unsure. #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social

Dr. Turner presents #ZEST adj study of MRD in pts with HR + w/ BRCA & TNBC all comers w/ niraparib as intervention 147 had ctDNA+, only 40 randomized Rad recurrence assoc w/ ⬆️ ctDNA level RFI 5.4 -> 11.4 mo w/ niraparib #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social

An Amazing Day 3⃣ at #SABCS24 🇺🇸 Our gratitude to our hosts and Collaborators SABCS for their amazing work‼️ The Stats on X are: ✅54 million IMpressions ✅8,8k Posts ✅Around 1,5k Participants WE ARE @OncoAlert 🚨

Join us in an hour, 2pm in Stars at Night to discuss artificial intelligence. I'm going to convince you it's not an abstract use for the future or only chatGPT but how we are using it TODAY at Sarah Cannon Research Institute in our clinics. #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social

Dr. metzger presents #PATINA Maint ET + HP +/- Palbo in 1st line ER+ and HER-2+ maint 📌29.1 vs. 44.3 mo PFS with Palbo w/ 52 mo f/u OS not signif yet Low counts, fatigue, and stomatitis AEs, discontinuations only 7% of pts though @sabcs.bsky.social #SABCS24 @oncoalert.bsky.social #bcsm

It's a difficult topic to discuss- weight. Hugely personal, not easy to change, but impt. 4% ⬆️ recurrence in pts w/ node + #bcsm obese vs. lean 2% ⬆️ recurrence in pts with N0 dz 📌Magnitude of effect larger among premeno. 📌ER + AND ER neg @sabcs.bsky.social #SABCS24 @oncoalert.bsky.social